Literature DB >> 11198888

A new era of cancer immunotherapy: converting theory to performance.

S A Rosenberg.   

Abstract

The major impact of recent scientific advances, such as the discovery of genes and gene products, has been to facilitate development of immunotherapies based on the specific stimulation of immune reactions against characterized tumor antigens.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 11198888     DOI： 10.3322/canjclin.49.2.70

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  5 in total

1.  Inferring relevant control mechanisms for interleukin-12 signaling in naïve CD4+ T cells.

Authors:  Stacey D Finley; Deepti Gupta; Ning Cheng; David J Klinke
Journal:  Immunol Cell Biol       Date:  2010-05-18       Impact factor: 5.126

2.  Ablation of Cbl-b provides protection against transplanted and spontaneous tumors.

Authors:  Jeffrey Y Chiang; Ihn Kyung Jang; Richard Hodes; Hua Gu
Journal:  J Clin Invest       Date:  2007-03-15       Impact factor: 14.808

3.  Follow-up analysis of a randomized phase III immunotherapeutic clinical trial on melanoma.

Authors:  Robert Suriano; Shilpi Rajoria; Andrea L George; Jan Geliebter; Raj K Tiwari; Marc Wallack
Journal:  Mol Clin Oncol       Date:  2013-03-20

4.  Serum levels of the cancer-testis antigen POTEE and its clinical significance in non-small-cell lung cancer.

Authors:  Qi Wang; Xuefei Li; Shengxiang Ren; Ningning Cheng; Mingchuan Zhao; Yishi Zhang; Jiayu Li; Weijing Cai; Chao Zhao; Wa Cao; Caicun Zhou
Journal:  PLoS One       Date:  2015-04-10       Impact factor: 3.240

5.  Ex vivo derived primary melanoma cells: implications for immunotherapeutic vaccines.

Authors:  Robert Suriano; Shilpi Rajoria; Andrea L George; Jan Geliebter; Marc Wallack; Raj K Tiwari
Journal:  J Cancer       Date:  2013-06-19       Impact factor: 4.207
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.